[Basophilic acute leukemias (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000209:etiology; D001491:Basophils; D001778:Blood Coagulation Disorders / Q000209:etiology; D001856:Bone Marrow Examination; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D006470:Hemorrhage / Q000209:etiology; D006651:Histocytochemistry; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D011379:Prognosis; D012075:Remission, Spontaneous
D003561:Cytarabine; D003630:Daunorubicin
Leucémies aiguës à basophiles